Physician Detail

David Michael Chaletsky, MD

Practice

Connecticut GI, PC

Specialty

Gastroenterology, Board Certified < Accepting new patients for this specialty
Internal Medicine, Board Certified < Not accepting new patients for this specialty

Areas of Interest

Barrett's Esophagus, Colorectal Cancer Screening, Enteroscopy, Gastroesophageal Reflux (GERD), Irritable Bowel Syndrome (IBS), Radiofrequency Ablation, Small Bowel Capsule Endoscopy

Physician Quicklink

https://hartfordhospital.org/DavidChaletsky

Institute URL

https://hartfordhealthcare.org/cancer

Phone

860.246.2571

Call for Appointment

Gender
Male

Languages
English


Office Locations


Hospitals and Organizations


Bio

A conversation with Dr. David Chaletsky, Gastroenterologist, Hartford Hospital about Treatment Options for Acid Re-flux Disease:

HHC: What is Acid Re-flux? It doesn’t always come in the form of heartburn, is that correct?

A. When acid from the stomach regurgitates up into the esophagus on a regular basis that is the condition called acid re-flux or GERD. It is quite common, occurs for many reasons, and often results in heartburn, but almost half of patients either have no symptoms or atypical issues such as persistent cough, throat clearing, or even chest pain.

HHC: What are the treatment options that Hartford Hospital offers to patients with Acid Re-flux?

A. Standard treatment would be medications either over the counter or prescription, as well as diet modification. This essentially neutralizes the acid but doesn’t fix the underlying problem of re-flux. For patients with severe issues, there are minimally invasive anti-re-flux surgeries that we offer to eliminate the re-flux.

HHC: For those patients with Acid Re-flux, who is at risk for developing esophageal cancer?

A. Everyone with acid re-flux is at risk. That’s why if you do have symptoms, it is important to see your doctor to determine your level of risk and whether you should be screened. Some individuals with a family history of esophagus cancer, long standing re-flux symptoms, and certain other risk factors are at higher risk.

q. How do you screen for possible Pre-cancer?

A. THE BEST METHOD IS A SIMPLE TEST CALLED AN UPPER ENDOSCOPY. A SHORT PROCEDURE PERFORMED BY A GASTROENTEROLOGIST UNDER SEDATION WHICH LOOKS DIRECTLY AT THE LINING OF THE ESOPHAGUS AND CAN ACCURATELY DETECT THE PRESENCE OR ABSENCE OF BARRETT’S ESOPHAGUS – PRE-CANCEROUS TISSUE WHICH, WHEN CAUGHT EARLY ENOUGH, CAN BE TREATED IN ORDER TO PREVENT PROGRESSION TO CANCER.

Q. If a pre-cancerous lesion is detected, what are the treatment options to remove it before turning to cancer?

A. EET – ENDOSCOPIC ERADICATION THERAPY. AT HARTFORD HOSPITAL, WE NAVIGATE OUR PATIENTS THROUGH A COORDINATED, TEAM APPROACH TO COMPLETELY REMOVE THE PRE-CANCROUS AREAS, AND IN SOME CASES WE ARE ABLE TO REMOVE AREAS THAT HAVE ALREADY TURNED CANCEROUS. WE OFFER THE FULL ARRAY OF ABLATION AND ENDOSCOPIC RESECTION TECHNOLOGIES.

Media


Education

Undergraduate

  • Brandeis University 1993 BA

Graduate School

  • Boston University School of Public Health 1995, MPH

Medical School

  • St. George's University School of Medicine 2001 MD

Residency

  • Albany Medical Center 2005, Internal Medicine

Fellowship

  • Albany Medical Center 2008, Gastroenterology


Did you know? 

Physicians can request updates and changes made to their profile.

Request a Change